|
1
|
Boyce BF, Yoneda T and Guise TA: Factors
regulating the growth of metastasis cancer in bone. Endocr Relat
Cancer. 6:333–347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mundy GR: Metastasis to bone: Causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roodman CD: Mechanism of bone metastasis.
N Engl J Med. 350:1655–1664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akhtari M, Mansuri J, Newman KA, Guise TM
and Seth P: Biology of brest cancer bone metastasis. Cancer Biol
Ther. 7:3–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coleman RE: Metastatic bone disease:
Clinical features, pathophysiology and treatment strategies. Cancer
Treat Rev. 27:165–176. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YC, Sosnoski DM and Mastro AM: Breast
cancer metastasis to the bone: Mechanisms of bone loss. Breast
Cancer Res. 12:2152010. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park BK, Zhang H, Zeng Q, Dai J, Keller
ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, et al: NF-kappaB in
breast cancer cells promotes osteolytic bone metastasis by inducing
osteoclastogenesis via GM-CSF. Nat Med. 13:62–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gonzalez-Suarez E, Jacob AP, Jones J,
Miller R, Roudier-Meyer MP, Enwert R, Pinkas J, Branstetter D and
Dougall WC: RANK ligand mediates progestin-induced mammary
epithelial proliferation and carcinogenesis. Nature. 468:103–107.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weilbaecher KN, Guise TA and McCauley LK:
Cancer to bone: A fatal attraction. Nat Rev Cancer. 11:411–425.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berrios RL and Arbiser JL: Effectiveness
of gentian violet and similar products commonly used to treat
pyodermas. Dermatol Clin. 29:69–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perry BN, Govindarajan B, Bhandarkar SS,
Knaus UG, Valo M, Sturk C, Carrillo CO, Sohn A, Cerimele F, Dumont
D, et al: Pharmacologic blockade of angiopoietin-2 is efficacious
against model hemangiomas in mice. J Invest Dermatol.
126:2316–2322. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Zheng Y, Fried LE, Du Y, Montano
SJ, Sohn A, Lefkove B, Holmgren L, Arbiser JL, Holmgren A and Lu J:
Disruption of the mitochondrial thioredoxin system as a cell death
mechanism of cationic triphenylmethanes. Free Radic Biol Med.
50:811–820. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamaguchi M, Vikulina1 T, Arbiser JL and
Weitzmann MN: Suppression of NF-κB activation by gentian violet
promotes osteoblastogenesis and suppresses osteoclastogenesis. Curr
Mol Med. 14:783–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoneda T, Williams PJ, Hiraga T, Niewolna
M and Nishimura R: A bone-seeking clone exhibits different
biological properties from the MDA-MB-231 parental human breast
cancer cells and a brain-seeking clone in vivo and in vitro. J Bone
Miner Res. 16:1486–1495. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi M, Zhu S, Weitzmann MN, Snyder
JP and Shoji M: Curcumin analog UBS109 prevents bone marrow
osteoblastogenesis and osteoclastogenesis disordered by coculture
with breast cancer MDA-MB-231 bone metastatic cells in vitro. Mol
Cell Biochem. 401:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Misawa H, Inagaki S and Yamaguchi M:
Suppression of cell proliferation and deoxyribonucleic acid
synthesis in cloned rat hepatoma H4-II-E cells overexpressing
regucalcin. J Cell Biochem. 84:143–149. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaguchi M and Daimon Y: Overexpression
of regucalcin suppresses cell proliferation in cloned rat hepatoma
H4-II-E cells: Involvement of intracellular signaling factors and
cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Izumi T and Yamaguchi M: Overexpression of
regucalcin suppresses cell death in cloned rat hepatoma H4-II-E
cells induced by tumor necrosis factor-alpha or thapsigargin. J
Cell Biochem. 92:296–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meijer L, Borgne A, Mulner O, Chong JP,
Blow JJ, Inagaki N, Inagaki M, Deleros JG and Moulinoux JP:
Biochemical and cellular effects of roscovitine, a potent and
selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and
cdk5. Eur J Biochem. 243:527–536. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singh SV, Herman-Antosiewice A, Singh AV,
Lew KL, Strivastava SK, Kamath R, Brown KD, Zhang L and Baskaran R:
Sulforaphan-induced G2/M phase cell cycle arrest involves
checkpoint kinase 2-mediated phosphorylation of cell division cycle
25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen S, Wang Y, Ruan W, Wang X and Pan C:
Reversing multidrug resistance in hepatocellular carcinoma cells by
inhibiting extracellular signal-regulated kinase/mitogen-activated
protein kinase signaling pathway activity. Oncol Lett. 8:2333–2339.
2014.PubMed/NCBI
|
|
22
|
Chen QW, Edvinsson L and Xu CB: Role of
ERK/MAPK in endothelin receptor signaling in human aortic smoth
muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Serrano-Nascimento C, da Silva Teixeira S,
Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute
inhibitory effect of iodide excess on sodium/iodide symporter
expression and activity involves the PI3K/Akt signaling pathway.
Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Palangat M, Grass JA, Langelier MF,
Coulombe B and Landick R: The RPB2 flap loop of human RNA
polymerase II is dispensable for transcription initiation and
elongation. Mol Cell Biol. 31:3312–3325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang SC and Chen YC: Novel therapeutic
targets for pancreatic cancer. World J Gastroenterol.
20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamaguchi M, Vikulina T and Weitzmann MN:
Gentian violet inhibits MDA-MB-231 human breast cancer cells
proliferation, and reverses the stimulation of osteoclastogenesis
and suppression of osteoblast activity induced by cancer cells.
Oncol Rep. 34:2156–2162. 2015.PubMed/NCBI
|
